Press Releases

DUBLIN--(BUSINESS WIRE)-- The "Global Self-Service Kiosks Market, Forecast to 2022" report has been added to ResearchAndMarkets.com's offering. The market had revenue of $8,916.8 million in 2017 and is expected to grow at a CAGR of 3.0% between 2017 and 2022. The unit shipment of self-servi

HIGH POINT, N.C.--(BUSINESS WIRE)-- vTv Therapeutics Inc. (Nasdaq: VTVT) today announced that company management will present a corporate overview at the Piper Jaffray 30th Annual Healthcare Conference on Tuesday, Nov. 27, 2018 at 2:10 p.m. ET in New York City. A live webcast of the presentation can be accessed 

BOSTON--(BUSINESS WIRE)-- Cycle Pharmaceuticals (Cycle) is pleased to announce that it has obtained the required stability data to extend the shelf life of NITYR™ (nitisinone) tablets from 24 to 36 months at room temperature. This press release features multimedia. View the full release here: https://www.bus

SANTERAMO IN COLLE, Bari, Italy--(BUSINESS WIRE)-- Natuzzi S.p.A. (NYSE:NTZ) (“Natuzzi” or “the Company”) will disclose third quarter and first nine months 2018 financial results on Friday November 30, 2018 after the close of trading on the New York Stock Exchange. The Company will host a conference call on Monday De

CINCINNATI--(BUSINESS WIRE)-- Today, Secret kick-starts a conversation around closing the gender wage gap with the launch of its “

DUBLIN--(BUSINESS WIRE)-- The "Global Antisense and RNAi Therapeutics Market 2019-2023" report has been added to ResearchAndMarkets.com's offering. The Global Antisense and RNAi Therapeutics Market is projected to grow at a CAGR of 8.67% during the period 2019-2023. The report has be

CRANBURY, N.J.--(BUSINESS WIRE)-- Pharmacy Times Continuing Education™ (PTCE), a leader in continuing education for retail, health-system, managed care and specialty pharmacists, will conduct three continuing education symposia at the 53rd American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting and Exhibition on Dec. 3 and Dec. 5 at the Anaheim Convention Cen

NEEDHAM, Mass.--(BUSINESS WIRE)-- PTC (NASDAQ: PTC) has once again been named one of the Top Places to Work in Massachusetts in the 11th annual employee-based survey

ELKHART, Ind.--(BUSINESS WIRE)-- Thor Industries, Inc. (NYSE:THO) today announced it has appointed Mark Trinske as Vice President of Investor Relations. In this role, Mr. Trinske will be responsible for all aspects of Thor’s investor relations program. “We are pleased to welcome Mark Trinske as our new Vice President of Investor Relations,” said Bob Martin, Thor President and CEO. "

STAMFORD, Conn.--(BUSINESS WIRE)-- WWE® (NYSE: WWE) today announced that Chicago will host Survivor Series® Weekend in 2019 with Survivor Series, Monday Night Raw®, SmackDown® Live and NXT® TakeOver® all taking place at Allstate Arena over four

IRVING, Texas--(BUSINESS WIRE)-- Fluor Corporation (NYSE: FLR) announced today that Compagnie des Bauxites de Guinée (CBG) has achieved first ore at its Bauxite Produ

STONY BROOK N.Y.--(BUSINESS WIRE)-- Applied DNA Sciences Inc. (NASDAQ:APDN, “Applied DNA,” “the Company”), the leader in large-scale PCR-based DNA

BELLEVUE, Wash.--(BUSINESS WIRE)-- Big Ten fans heading to Indianapolis for the 2018 Big Ten Football Championship Game presented by Discover, get ready to amp your spirit to an all-time high. BTN and T-Mobile (NASDAQ: TMUS) today announced the

DUBLIN--(BUSINESS WIRE)-- The "Seafood Processing Equipment Market Size, Share & Trends Analysis Report by Product (Frozen, Smoked, Canned, Dried), By Equipment (Slaughtering, Gutting, Scaling, Filleting), And Segment Forecasts, 2018 - 2025" report has been added to ResearchAndMarkets.com's offering.

ROCKVILLE, Md.--(BUSINESS WIRE)-- GlycoMimetics, Inc. (NASDAQ: GLYC) announced today dosing of the first patient in the company’s Phase 3 clinical trial of uproleselan (GMI-1271) in relapsed/refractory AML. The trial’s protocol provides for administration of the investigational drug in combination with MEC (mitoxantrone, etoposide and ara-C) or in combination with FAI (fludarabine, ara-C and idarubi